Sustainability | December 17, 2025
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
Adverse events were similar to placebo, and no AP-101-induced antibody responses were detected
It's a development that marks a potential breakthrough for people living with the rare and debilitating disease Duchenne muscular dystrophy (DMD)
_Logo_256_384.png){kind=logo}
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
Health Canada’s approval was based on a comprehensive evaluation of analytical, nonclinical, and clinical data
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
The trial tested six injectable doses and three oral doses over as long as 36 weeks
Subscribe To Our Newsletter & Stay Updated
